GIM
UTHR icon

Greylin Investment Management’s United Therapeutics UTHR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$430K Sell
1,350
-75
-5% -$23.9K 0.07% 62
2024
Q1
$327K Sell
1,425
-25
-2% -$5.74K 0.05% 62
2023
Q4
$319K Sell
1,450
-125
-8% -$27.5K 0.06% 61
2023
Q3
$356K Hold
1,575
0.06% 58
2023
Q2
$348K Sell
1,575
-400
-20% -$88.3K 0.06% 57
2023
Q1
$442K Sell
1,975
-300
-13% -$67.2K 0.08% 55
2022
Q4
$633K Sell
2,275
-75
-3% -$20.9K 0.12% 49
2022
Q3
$492K Sell
2,350
-50
-2% -$10.5K 0.1% 51
2022
Q2
$566K Sell
2,400
-150
-6% -$35.4K 0.11% 51
2022
Q1
$457K Sell
2,550
-6,891
-73% -$1.23M 0.08% 60
2021
Q4
$2.04M Sell
9,441
-111
-1% -$24K 0.38% 38
2021
Q3
$1.76M Sell
9,552
-4,660
-33% -$860K 0.36% 40
2021
Q2
$2.55M Sell
14,212
-18,024
-56% -$3.23M 0.49% 34
2021
Q1
$5.39M Sell
32,236
-3,588
-10% -$600K 1.12% 21
2020
Q4
$5.44M Sell
35,824
-17,365
-33% -$2.64M 1.27% 17
2020
Q3
$5.37M Sell
53,189
-61,979
-54% -$6.26M 1.43% 15
2020
Q2
$13.9M Sell
115,168
-18,755
-14% -$2.27M 3.93% 6
2020
Q1
$12.7M Sell
133,923
-23,293
-15% -$2.21M 3.95% 5
2019
Q4
$13.8M Sell
157,216
-20,445
-12% -$1.8M 3.06% 10
2019
Q3
$14.2M Buy
177,661
+38,683
+28% +$3.08M 3.38% 8
2019
Q2
$10.8M Buy
138,978
+21,200
+18% +$1.65M 2.44% 11
2019
Q1
$13.8M Sell
117,778
-3,015
-2% -$354K 3.1% 9
2018
Q4
$13.2M Buy
+120,793
New +$13.2M 3.15% 10
2018
Q3
Sell
-118,703
Closed -$13.4M 82
2018
Q2
$13.4M Buy
118,703
+80,006
+207% +$9.05M 2.91% 9
2018
Q1
$4.35M Buy
+38,697
New +$4.35M 0.94% 20
2017
Q4
Sell
-3,375
Closed -$396K 78
2017
Q3
$396K Buy
3,375
+400
+13% +$46.9K 0.09% 60
2017
Q2
$386K Buy
2,975
+885
+42% +$115K 0.09% 62
2017
Q1
$283K Buy
+2,090
New +$283K 0.07% 70